Tempus

(Senior) Medical Science Liaison - Heartland

Indiana, United States

Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, BiotechnologyIndustries

Medical Science Liaison (MSL) / Senior Medical Science Liaison (Sr. MSL) - Oncology

Employment Type: Full time

Location Type: Field-based (Heartland territory: MO and IN regions of the US)

Position Overview:

Tempus is seeking a high-performing and experienced Medical Science Liaison (MSL) or Senior Medical Science Liaison (Sr. MSL) to support the commercial and educational objectives of the company. This field-based role requires a strong clinical and scientific background in oncology and genomic testing. The MSL will be responsible for educating healthcare providers about Tempus assays and technologies, leveraging the company's proprietary platform that connects real-world evidence to deliver actionable insights for physicians.

Responsibilities:

  • Commercial and Educational Support: Function as a sales and commercial team support and a regional expert for Tempus oncology assays.
  • KOL Engagement: Promote the exchange of clinical, scientific, and technical information with Key Opinion Leaders (KOLs) and other physicians in the field of oncology.
  • Healthcare Provider Education: Facilitate education for a broader healthcare provider community within the region (KOLs, community physicians, medical directors, and other HCPs) regarding Tempus oncology products. This includes proactive and reactive communication of scientific data through in-person or virtual presentations.
  • Internal Scientific Education: Provide scientific education for internal stakeholders in collaboration with the Learning & Development team.
  • Conference Participation: Attend conferences and other key meetings, providing comprehensive meeting synopses and summaries of high-impact abstracts, posters, and oral presentations.
  • Market Intelligence: Continuously update internal stakeholders on relevant medical and scientific knowledge and proactively share market intelligence.

Required Skills:

  • Fundamental understanding of molecular oncology and related patient management algorithms.
  • Existing KOL relationships in the field of oncology.
  • Working knowledge of genomic laboratory-developed testing (LDT).
  • Familiarity with CLIA’88’, CAP, and Sunshine Act (2013).
  • Public speaking skills and the ability to effectively communicate relevant scientific topics and concepts.
  • Exceptional interpersonal communication skills.
  • Strong inter- and intradepartmental management skills.
  • Ability to educate and train.
  • Self-starter with an ownership mindset, capable of working and delivering on tight timelines.
  • Ability to travel up to 50%.

Education and Experience:

  • Education: Advanced scientific or medical degree (PhD, PharmD, MD, MSN, BSN).
  • Experience:
    • Basic understanding of oncology required.
    • Basic understanding of molecular testing strongly preferred.
    • Preferred: 1+ years of MSL experience in diagnostics, biotech, or pharmaceutical industries.

Company Information:

Tempus is driven by a passion for precision medicine and advancing the healthcare industry. Our proprietary platform connects an entire ecosystem of real-world evidence to deliver real-time, actionable insights to physicians, providing critical information about the right treatments for the right patients, at the right time.


Tempus is an equal opportunity employer. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.

Skills

oncology
genomic testing
clinical communication
scientific education
conference presentation
market intelligence

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI